Abstract
e19021Background: Allogeneic hematopoietic stem cell transplant (HSCT) is a potentially curative option for severe aplastic anemia (SAA) or hypoplastic myelodysplasia (h-MDS). However, there is no ...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
